Welcome to our dedicated page for RCM TECHNOLOGIES SEC filings (Ticker: RCMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RCM Technologies, Inc. filings document the reporting obligations of a Nevada-incorporated operating company with common stock registered on Nasdaq under the symbol RCMT. Its Form 8-K reports cover financial results, material agreements, revolving credit and loan amendments, direct financial obligations, changes in certifying accountants, and related internal control disclosures.
The company’s proxy materials address board matters, executive compensation, equity award information, and pay-versus-performance disclosure. Periodic and notice filings provide formal records around annual reporting, late-filing notifications, consolidated financial statements, risk and control matters, and the governance framework supporting RCM Technologies’ health care, engineering, information technology, life sciences, data, and solutions services.
RCM TECHNOLOGIES, INC. (RCMT) received a Rule 144 notice stating that officer Kevin D. Miller plans to sell up to 100,000 shares of common stock, par value $0.05 per share, through Baird, with an aggregate market value of $3,700,000.00, on or after August 14, 2026, on NASDAQ. The notice states that 7,110,759 shares were outstanding as of August 12, 2026, as reported in the most recent Form 10-Q; this is a baseline figure, not the amount being sold. The shares to be sold were acquired via salary exchange in 2020 and 2021, an employee stock purchase plan in 2021, and an open market purchase in June 2020, in addition to equity compensation and RSU vesting.
RCM Technologies executive Michael Saks, Division President, HC Services, reported mixed equity activity in RCMT common stock. On August 13, 2026 he acquired 4,000 time-based restricted stock units and 2,904 shares from vesting of performance stock units, all as employment compensation. On August 14, 2026 a Rule 10b5-1 trading plan executed nondiscretionary sales of 6,792 shares at a weighted average price of about $32.50 within a $32.50–$32.75 range and 5,000 shares at $35.00 per share.
RCM Technologies, Inc. reported that its CFO, Kevin D. Miller, acquired 8,362 shares of Common Stock on August 13, 2026 through a grant of time-based restricted stock units received as employment compensation. Following this award, Miller holds 428,362 shares of RCM Technologies Common Stock directly.
RCM Technologies, Inc. has a notice covering a potential sale of up to 100,000 shares of its common stock, par value $0.05 per share, through Baird on NASDAQ. The filing lists an aggregate market value of $3,500,000 for these shares and notes 7,110,759 shares outstanding. It also references earlier common stock issuances from restricted share vesting in 2021 and 2023 as equity compensation.
RCM Technologies, Inc. reports solid growth for the thirteen and twenty-six weeks ended July 4, 2026. Quarterly revenue rose to $93.8 million, up from $78.2 million a year earlier, driven mainly by a $13.0 million increase in Engineering and growth in Specialty Health Care and Life Sciences, Data and Solutions. Quarterly net income increased to $4.9 million from $3.8 million, with diluted EPS of $0.68 versus $0.50.
For the twenty-six-week period, revenue reached $176.9 million and net income $8.7 million. Operating cash flow strengthened to $13.5 million, supporting share repurchases of 348,366 shares at an average price of $19.03 and a modest reduction in borrowings under the revolving credit facility to $23.4 million. Cash increased to $6.6 million while total assets stayed roughly flat. The company notes significant customer concentration, with three customers representing up to 23.3%, 13.5% and 13.3% of consolidated revenue, and continues to operate within its expanded credit facility, with $32.7 million of additional borrowing availability.
RCM Technologies reported relatively stable results for the thirteen weeks ended April 4, 2026, with revenue of $83.0 million versus $84.5 million a year earlier. Net income was $3.8 million, down slightly from $4.2 million, and diluted earnings per share were $0.52 compared with $0.54.
Business mix shifted meaningfully. Specialty Healthcare revenue rose to $48.1 million, while Engineering declined to $26.1 million and Life Sciences, Data and Solutions eased to $8.8 million. Gross margin improved modestly to 26.5%, but higher selling, general and administrative expenses kept operating income at $5.9 million versus $6.6 million.
Operating cash flow was $2.7 million, well below the prior period’s $16.7 million, largely due to working-capital swings in receivables and transit balances. The company continued to use its balance sheet actively, repurchasing 348,366 shares at an average price of $19.03 and increasing borrowings on its revolving credit facility to $28.8 million, with $33.3 million of additional availability.
RCM Technologies, Inc. Division President of Healthcare Services Michael Saks reported an open-market sale of 1,208 shares of Common Stock at $32.50 per share. The transaction, executed on May 4, 2026, was made under a pre-established Rule 10b5-1 trading plan. Following this sale, Saks directly holds 89,267 shares of the company’s common stock.
RCM Technologies CFO Kevin D. Miller reported an open-market sale of common stock. On May 4, 2026, he sold 19,066 shares at a weighted average price of $32.03 per share, in a nondiscretionary transaction under a Rule 10b5-1 trading plan. After the sale, he directly holds 420,000 shares of RCM Technologies common stock.
Michael Saks submitted a Form 144 notice reporting proposed and recent sales of Common Stock in RCMT. The filing lists proposed sales from Employee Stock Purchase Plans of 865 and 343 shares and two recent dispositions: 4,864 shares sold on 04/16/2026 for $145,920 and 136 shares sold on 04/15/2026 for $4,080.
The broker/dealer of record is Morgan Stanley Smith Barney LLC. The filing records the sales and gives basic transaction amounts and dates; it does not include additional narrative or conditions.